Risk-based contracts may be the future of palliative care reimbursement as Medicare Advantage continues to ascend. The simple term “value-based care” belies its complexity. The term can refer to any number of payment models that are designed to reduce total cost of care and improve outcomes. While most palliative care remains locked in the fee-for-service […]
The U.S. Department of Justice’s (DOJ) lawsuit against Amedisys Inc. (Nasdaq: AMED) and UnitedHealth Group (NYSE: UNH) will go to mediation on Aug. 18. The DOJ sued the two companies starting in November of last year to block the UnitedHealth Group subsidiary Optum from acquiring Amedisys due to antitrust concerns. The case will now go […]
Amedisys Inc. (Nasdaq: AMED) saw hospice revenue growth during the fourth quarter of 2024 despite merger-related costs associated with its pending acquisition by UnitedHealth Group (NYSE: UNH). The company’s hospice business saw net service revenues of $212.9 million during the fourth quarter of 2024, up from $20.6 million year over year. For the full year […]
A U.S. Justice Department (DOJ) victory in its lawsuit to block UnitedHealth Group’s (NYSE: UNH) acquisition of Amedisys (Nasdaq: AMED) is unlikely to have a cooling effect on hospice M&A, according to some experts. The UnitedHealth Group subsidiary Optum in June 2023 agreed to acquire Amedisys in a $3.3 billion deal. Optum in February 2023 […]
UnitedHealth Group Inc. (NYSE: UNH) is withdrawing its motion to dismiss the U.S. Department of Justice’s (DOJ) antitrust lawsuit regarding the company’s plans to acquire Amedisys in a $3.3 billion deal. UnitedHealth Group is one of the largest companies in the country and has an array of associated business lines. Should the deal go through, […]
Amedisys’ (Nasdaq: AMED) has halted the divestiture of some of its home health and hospice locations to Texas-based VitalCaring. Amedisys in June announced an agreement to sell some of its locations to the private equity-backed home health and hospice provider VitalCaring. The agreement included potentially more than 100 locations. The VitalCaring transaction was contingent on […]
UnitedHealth Group (NYSE: UNH) subsidiary Optum entered a new waiver agreement that has delayed the deadline to complete its $3.3 billion acquisition of Amedisys (Nasdaq: AMED). The agreement comes on the heels of an antitrust lawsuit that the U.S. Department of Justice (DOJ) filed last month to block the transaction due to concerns that it […]
Hospice News explores the issues garnering growing attention in end-of-life care delivery in seven of this year’s “hidden gem” stories. Topics span trends related to program integrity, workforce development, health equity, service diversification and the keys to hospices’ growth strategies. Hospice Investors to Watch Hospice merger and acquisition (M&A) activity has seen a cooling period […]
Nautic Partners and The Vistria Group, the private equity backers of home health and hospice provider Vital Caring, are mulling a potential appeal of a federal court’s recent decision in a dispute with Encompass Health (NYSE: EHC) and Enhabit Inc. (NYSE: EHAB). A federal judge in Delaware on Monday ordered VitalCaring, Nautic and Vistria to […]
The rationale behind the U.S. Justice Department’s lawsuit against Optum and Amedisys (Nasdaq: AMED) is multi-faceted, citing potential adverse impacts on competition, home-based care workers and payers. Optum, a subsidiary of UnitedHealth Group (NYSE: UNH) in June 2023 penned its agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
